{"organizations": [], "uuid": "6f28eef76bb12f4ad620dc30df67558eb56492df", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-proteostasis-receives-endorsement/brief-proteostasis-receives-endorsement-from-cystic-fibrosis-foundation-for-study-of-pti-428-in-cf-subjects-on-background-symdeko-therapy-idUSFWN1RU0OV", "country": "US", "domain_rank": 408, "title": "BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T15:08:00.000+03:00", "replies_count": 0, "uuid": "6f28eef76bb12f4ad620dc30df67558eb56492df"}, "author": "", "url": "https://www.reuters.com/article/brief-proteostasis-receives-endorsement/brief-proteostasis-receives-endorsement-from-cystic-fibrosis-foundation-for-study-of-pti-428-in-cf-subjects-on-background-symdeko-therapy-idUSFWN1RU0OV", "ord_in_thread": 0, "title": "BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "proteostasis therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 17, 2018 / 12:08 PM / Updated 10 minutes ago BRIEF-Proteostasis Receives Endorsement From Cystic Fibrosis Foundation For Study Of PTI-428 In CF Subjects On Background Symdeko Therapy Reuters Staff 1 Min Read \nApril 17 (Reuters) - Proteostasis Therapeutics Inc: \n* PROTEOSTASIS RECEIVES ENDORSEMENT FROM THE CYSTIC FIBROSIS FOUNDATION’S THERAPEUTIC DEVELOPMENT NETWORK FOR THE STUDY OF THE COMPANY’S AMPLIFIER, PTI-428, IN CF SUBJECTS ON BACKGROUND SYMDEKO™ THERAPY Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-17T15:08:00.000+03:00", "crawled": "2018-04-17T15:21:47.023+03:00", "highlightTitle": ""}